Formoterol Fumarate Inhalation Solution
Product Images NDC 76204-030

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate Inhalation Solution (NDC 76204-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01-chemical-structure (01 Chemical Structure)

Chemical structure of formoterol fumarate dihydrate, showing the molecular arrangement of formoterol fumarate along with the two water molecules of hydration.*

FDA Label Image

04-image-01 (04 Image 01)

An instructional illustration showing the preparation of a respiratory inhalation device. It depicts a hand holding the inhaler and placing a capsule or component into the device's chamber. This is likely part of the use or assembly process for Formoterol Fumarate Inhalation Solution.*

FDA Label Image

05-image-02 (05 Image 02)

An instructional illustration showing a hand holding a nebulizer mouthpiece or inhalation device with medication being dispensed or connected. This image is related to the use or assembly of an inhalation solution device.*

FDA Label Image

06-image-03 (06 Image 03)

An instructional illustration showing two steps of using an inhalation device. The first panel depicts a person placing the inhaler mouthpiece directly between their lips. The second panel shows the person using the inhaler with a spacer or holding chamber attached to the mouthpiece.*

FDA Label Image

08-formoterol-60ct (08 Formoterol 60ct)

Packaging label for Formoterol Fumarate Inhalation Solution 20 mcg / 2 mL vial. The label indicates that it is a sterile unit dose solution, individually wrapped for oral inhalation only. Manufactured and labeled by Ritedose Pharmaceuticals, LLC. The carton contains 60 individually wrapped 2 mL vials. Storage conditions and patient information are also included on the packaging.*

FDA Label Image

Formoterol-30ct (Formoterol 30ct)

Packaging label for Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial, a respiratory inhalation solution by Ritedose Pharmaceuticals, LLC. The carton indicates it contains 30 individually wrapped sterile unit dose vials. The label includes usage instructions, storage conditions, and barcodes.*

FDA Label Image

Mean-fev1-12weeks (Mean Fev1 12weeks)

Line graph titled 'Mean FEV1 at Endpoint after 12 Weeks of Treatment' comparing mean FEV1 in liters over 12 hours between Formoterol Fumarate Inhalation Solution 20 mcg and placebo groups. The graph shows data points for two groups (N=123 for Formoterol, N=114 for placebo) with Formoterol consistently having higher mean FEV1 values than placebo.*

FDA Label Image

Mean-fev1-day1 (Mean Fev1 Day1)

A line graph titled 'Figure 1: Mean FEV1 at Day 1' showing mean FEV1 in liters on the vertical axis and time in hours on the horizontal axis up to 12 hours. The graph compares Formoterol Fumarate Inhalation Solution 20 mcg (N=123) and placebo (N=114), with Formoterol data plotted as diamonds and placebo as triangles, illustrating higher mean FEV1 values for Formoterol over the time period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.